68 FR 72 pgs. 18261-18262 - Manufacturer of Controlled Substances; Notice of Application
Type: NOTICEVolume: 68Number: 72Pages: 18261 - 18262
FR document: [FR Doc. 03-9228 Filed 4-14-03; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on May 13, 2002, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18 Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substance listed below:
| Drug | Schedule |
|---|---|
| N-Ethylamphetamine (1475) | I |
| 4-Methoxyamphetamine (7411) | I |
| 2,5-Dimethoxyamphetamine (7396) | I |
| Difenoxin (9168) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Pentobarbital (2270) | II |
| Methylphenidate (1724) | II |
| Secobarbital (2315) | II |
| Meperidine (9230) | II |
| Codeine (9050) | II |
| Oxycodone (9143) | II |
| Diphenoxylate (9170) | II |
| Hydrocodone (9193) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Alfentanil (9737) | II |
| Sufentanil (9740) | II |
| Fentanyl (9801) | II |
| Dextropropoxyphene (9273) | II |
The firm plans to bulk manufacture the listed controlled substances to produce products for distribution to its customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD), and must be filed no later than 60 days from publication.
Dated: April 3, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 03-9228 Filed 4-14-03; 8:45 am]
BILLING CODE 4410-09-M